NANOMEDICINES: CHARTING A ROADMAP TO COMMERCIALIZATION
On 6-7 March 2013, the Nanomedicines Alliance will be holding a Industry Symposium: Charting a Road to Commercialization. The Symposium will address:
- desigining nanomedicines
- preclinical pharmacology
- chemistry, manufacturing & controls
- toxicology/ADME and
- clinical studies
through podium presentations, breakouts sessions and poster sessions.